Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.00p
   
  • Change Today:
    -0.40p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 1,977,599
  • Market Cap: £50.27m
  • RiskGrade: 328

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £148,846
Lisa Baderoon 583,963 £58,396
Tim Franklin 525,000 £52,500

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £2,510,804
Luca & Associates AG 22,000,000 £2,200,000
Invesco Ltd 17,872,341 £1,787,234
Aviva Investors Global 11,285,180 £1,128,518
Alora Pharmaceuticals LLC 10,909,091 £1,090,909
M&G Investments 7,600,000 £760,000
Prudential plc 7,600,000 £760,000
Capital Income Builder 4,870,367 £487,037
Dr R Zimmer 4,551,553 £455,155
Odey Asset Management 3,433,319 £343,332
Rhone Trustees (Switzerland) SA 3,386,000 £338,600
Pictet Overseas Trust Corporation Limited 3,287,500 £328,750

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 10.00p
Change Today -0.40p
% Change -3.85 %
52 Week High 17.60p
52 Week Low 1.09p
Volume 1,977,599
Shares Issued 502.72m
Market Cap £50.27m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 04-Nov-2025

Time Volume / Share Price
10:08 90,104 @ 9.85p
11:05 108 @ 10.10p
11:02 2,000 @ 10.04p
10:59 49,854 @ 10.00p
10:59 1,700 @ 9.96p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page